Table 1.
Recommendations on individual diet and lifestyle factors for patients with localized and advanced prostate cancer.‡
Localized prostate cancer | Advanced prostate cancer | |
---|---|---|
Dietary factors | ||
Lycopene/tomato products*** | [17–19] | [20] |
Green tea** | [9, 10] | |
Avoidance of non-prescribed vitamin and mineral supplements (e.g., selenium)** | [51,52] | |
Coffee* | ||
Cruciferous vegetables* | ||
Fish* | ||
Larrea tridentata* | ||
Mushrooms* | ||
Vegetable-derived fats* | ||
Avoidance of dairy* | ||
Avoidance of eggs* | ||
Avoidance of poultry with skin* | ||
Avoidance of processed red meat* | ||
Avoidance of saturated fat* | ||
Milk thistle | [55] | |
Pomegranate | [32] | [33, 34] |
Soy | [19, 37–41] | [42–44] |
Omega-3 fatty acids | [17, 28–30] | |
Lifestyle factors | ||
Pelvic floor muscle training**** | [64–68, 71] | |
Pilates*** | [71] | |
Exercise**** | [76–78, 85, 86, 88] | [76, 78, 79, 81–89] |
Healthy body mass index† | ||
Smoking cessation† | ||
Guided imagery/progressive muscle relaxation*** | [97] | |
Qigong** | [99] | |
Massage** | [98] | |
Acupuncture* | ||
Hypnosis | [94] |
= Citations are provided for factors with RCTs with a placebo/usual care control group in patients with localized (including post-radical prostatectomy/radiation therapy) and advanced prostate cancer (including patients on androgen deprivation therapy).
Absence of * = Equivocal benefit based on available evidence
= Evidence leans toward potential benefit based on at least one observational study or RCT without a placebo control arm
= Evidence leans toward potential benefit based on at least one placebo-controlled RCT, but clinical significance is modest
= Evidence leans toward potential benefit based on at least one placebo-controlled RCT with clinically significant effect
= Well-established benefit based on two or more placebo-controlled RCTs with clinically significant effect
= Overwhelming observational evidence suggests benefit despite lack of RCTs focused on this factor alone.